🇺🇸 FDA
Pipeline program

Antimicrobial agent

LAI-Nu3-CLIN005

Phase 2 small_molecule active

Quick answer

Antimicrobial agent for Diabetic Foot Ulcers (DFUs) is a Phase 2 program (small_molecule) at Lakewood-Amedex Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Lakewood-Amedex Biotherapeutics
Indication
Diabetic Foot Ulcers (DFUs)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials